comparemela.com

Latest Breaking News On - Trista morrison - Page 6 : comparemela.com

Saniona AB: Saniona to participate in multiple upcoming virtual investor conferences

PRESS RELEASE January 5, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that it will present at multiple upcoming virtual

United statesTrista morrisonEventupdate janHc andersen capital company introductionSci partnersAnnual corporate accessChief communicationsRami levinChief communications officerNasdaq stockholm smallUpdate jan feb

Saniona AB: Saniona Initiates Phase 2b Clinical Trial of Tesomet for Prader-Willi Syndrome

PRESS RELEASE December 28, 2021 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced the initiation of a Phase 2b clinical trial of Tesomet

United statesNew zealandUnited kingdomTrista morrisonPaige rivardRudolf baumgartnerMerling butlerUniversity of kansas medical centerInternational prader willi syndrome organisationTrial initiation pressFoundation for prader willi researchPrader willi syndrome association united statesHead of clinical development at sanionaBehavioral sciencesDivision of researchChief medical officer

Investegate |Saniona AB Announcements | Saniona AB: Saniona Initiates Phase 2b Clinical Trial of Tesomet for Prader-Willi Syndrome

Investegate announcements from Saniona AB, Saniona Initiates Phase 2b Clinical Trial of Tesomet for Prader-Willi Syndrome

United statesNew zealandUnited kingdomTrista morrisonPaige rivardRudolf baumgartnerMerling butlerUniversity of kansas medical centerInternational prader willi syndrome organisationFoundation for prader willi researchPrader willi syndrome association united statesHead of clinical development at sanionaBehavioral sciencesDivision of researchSaniona initiates phaseClinical trial

Saniona AB: Saniona Chairman J Donald deBethizy and CEO Rami Levin, as well as additional members of the board and management, purchase Saniona shares in the open market

PRESS RELEASE December 2, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that the Chairman and the CEO, as well as additional

United statesTrista morrisonChief communications officerNasdaq stockholm smallPurchase dec

Investegate |Saniona AB Announcements | Saniona AB: Saniona Chairman J Donald deBethizy and CEO Rami Levin, as well as additional members of the board and management, purchase Saniona shares in the open market

Investegate announcements from Saniona AB, Saniona Chairman J. Donald deBethizy and CEO Rami Levin, as well as additional members of the board and management, purchase Saniona shares in the open market

United statesTrista morrisonSaniona chairmanRami levinChief communications officerNasdaq stockholm small capInvestegate announcementsInvestegate company announcementsSaniona abLobenewswire and globenewswire

vimarsana © 2020. All Rights Reserved.